JAMA Surgery : Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS
Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 23, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
The TAMARIN study: tamoxifen for MPNs
An upcoming study is investigating a new therapeutic strategy for the treatment of myeloproliferative neoplasms (MPNs). In this interview, Claire Harrison, MD, FRCP, FRCPath, from Guys and St Thomas...
Author: VJHemOnc
Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Repurposing Tamoxifen Therapy for Triple Negative Breast Cancer
Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics describes his other study that focuses on the use of tamoxifen therapy for triple negative breast cancer. This was recorded ...
Author: aacr2017
Added: 05/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 2, 2017 Category: Cancer & Oncology Source Type: podcasts
Abstract Overview: Novel Effect of Tamoxifen Therapy in Breast Cancer
Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics gives an overview of his abstract, Novel effect of tamoxifen therapy: disruption of ER-p53 interaction leading to altered ge...
Author: aacr2017
Added: 05/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 2, 2017 Category: Cancer & Oncology Source Type: podcasts
JAMA Oncology : Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer
Interview with Gretchen L. Gierach, PhD, author of Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 6, 2016 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer (JAMA Oncology)
Interview with Gretchen L. Gierach, PhD, author of Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 6, 2016 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Levonorgestrel intrauterine system (LNG-IUS) for endometrial protection in women with breast cancer taking tamoxifen to prevent recurrence
Alongside the thousands of Cochrane Reviews of the effects of treatments, there are some which investigate interventions intended to reduce the side effects of these treatments. One such review, updated in December 2015, looks at the levonorgestrel intrauterine system for endometrial protection in women with breast cancer who are taking tamoxifen. Irene Su, from the University of California in San Diego, USA, tells us more. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - December 11, 2015 Category: Journals (General) Authors: Cochrane Source Type: podcasts
se of Tamoxifen as Breast Cancer Prevention discussion with Dr. Muss
Dr. Muss discusses tamoxifen as breast cancer prevention.
Hyman B. Muss, MD, professor of oncology, University of North Carolina, director, Geriatric Oncology, Lineberger Comprehensive Cancer Center
Author: onclivetv
Added: 03/04/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 4, 2015 Category: Cancer & Oncology Source Type: podcasts
Gene Called USP9X and Tamoxifen Resistance
Author: oncozine
Added: 02/25/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 25, 2015 Category: Cancer & Oncology Source Type: podcasts
SABCS 2014: SOFT Trial Commentary by Dr. Sunil Verma
: Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS) versus tamoxifen in premenopausal women with hormone recep...
Author: oncologyeducation
Added: 12/11/2014 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2014 Category: Cancer & Oncology Source Type: podcasts
A Gene Called USP9X and Tamoxifen Resistance
Tamoxifen (Soltamox/Nolvadex®; AstraZeneca), an antagonist of the estrogen receptor α in ERα-positive breast cancer has been effective in most patients. The drug has been used for more than 40 years t...
Author: oncozine
Added: 08/22/2014 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2014 Category: Cancer & Oncology Source Type: podcasts
Metabolizing Tamoxifen
(Source: Mayo Clinic - Medical Edge Radio)
Source: Mayo Clinic - Medical Edge Radio - December 9, 2013 Category: Consumer Health Advice Authors: Mayo Clinic Source Type: podcasts
Transmuting tamoxifen
This week new research was published on the use of the SSRI (selective serotonin re-uptake inhibitor) antidepressants, in combination with the drug tamoxifen. For some time there have been concerns about prescribing them together, and a new study finally quantifies that, David Juurlink explains how.
Also this week, a child ’s early years will... (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 29, 2013 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Transmuting tamoxifen
This week new research was published on the use of the SSRI (selective serotonin re-uptake inhibitor) antidepressants, in combination with the drug tamoxifen. For some time there have been concerns about prescribing them together, and a new study finally quantifies that, David Juurlink explains how.
Also this week, a child’s early years will affect the rest of their life, in terms of medical as well as social and educational outcomes. Clyde Hertzman talks about what governments are, and should be, doing to help build a solid foundation.
Juliet Walker and Birte Twisselmann takes us through the week’s news. (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 29, 2013 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Julie R. Gralow, MD: Blood Clotting Issues and Tamoxifen
Dr. Julie Gralow sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) for a four-part interview. This is the third in the four-par...
Author: vitaloptions
Added: 02/26/2013 (Source: Oncology Tube)
Source: Oncology Tube - February 26, 2013 Category: Cancer & Oncology Source Type: podcasts
